These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach. Carroccio A; Iannitto E; Di Prima L; Cirrincione S; Troncone R; Paparo F; Trapani LG; Gucciardi A; Averna MR; Montalto G; Notarbartolo A Dig Dis Sci; 2003 Aug; 48(8):1530-6. PubMed ID: 12924648 [TBL] [Abstract][Full Text] [Related]
5. Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase. Uhlig HH; Lichtenfeld J; Osman AA; Richter T; Mothes T Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):1017-20. PubMed ID: 11007139 [TBL] [Abstract][Full Text] [Related]
6. Unexpected role of surface transglutaminase type II in celiac disease. Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Dieterich W; Trapp D; Esslinger B; Leidenberger M; Piper J; Hahn E; Schuppan D Gut; 2003 Nov; 52(11):1562-6. PubMed ID: 14570723 [TBL] [Abstract][Full Text] [Related]
8. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Lebreton C; Ménard S; Abed J; Moura IC; Coppo R; Dugave C; Monteiro RC; Fricot A; Traore MG; Griffin M; Cellier C; Malamut G; Cerf-Bensussan N; Heyman M Gastroenterology; 2012 Sep; 143(3):698-707.e4. PubMed ID: 22750506 [TBL] [Abstract][Full Text] [Related]
9. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and immuno-pathological aspects of tissue transglutaminase in coeliac disease. Roth EB; Sjöberg K; Stenberg P Autoimmunity; 2003 Jun; 36(4):221-6. PubMed ID: 14563015 [TBL] [Abstract][Full Text] [Related]
11. Transglutaminase-mediated cross-linking of a peptic fraction of omega-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. Palosuo K; Varjonen E; Nurkkala J; Kalkkinen N; Harvima R; Reunala T; Alenius H J Allergy Clin Immunol; 2003 Jun; 111(6):1386-92. PubMed ID: 12789243 [TBL] [Abstract][Full Text] [Related]
12. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713 [TBL] [Abstract][Full Text] [Related]
13. Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. Caputo I; Barone MV; Lepretti M; Martucciello S; Nista I; Troncone R; Auricchio S; Sblattero D; Esposito C Biochim Biophys Acta; 2010 Sep; 1802(9):717-27. PubMed ID: 20553859 [TBL] [Abstract][Full Text] [Related]
14. Localization of tissue transglutaminase and N (epsilon)-(gamma) -glutamyl lysine in duodenal cucosa during the development of mucosal atrophy in coeliac disease. Sakly W; Sriha B; Ghedira I; Bienvenu F; Ayadi A; Sfar MT; Lachaux A; Korbi S; Bienvenu J; Fabien N Virchows Arch; 2005 Jun; 446(6):613-8. PubMed ID: 15891906 [TBL] [Abstract][Full Text] [Related]
15. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease. Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165 [TBL] [Abstract][Full Text] [Related]
16. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay. Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953 [TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent. Biagi F; Campanella J; Laforenza U; Gastaldi G; Tritto S; Grazioli M; Villanacci V; Corazza GR Dig Liver Dis; 2006 Sep; 38(9):652-8. PubMed ID: 16916632 [TBL] [Abstract][Full Text] [Related]
18. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411 [TBL] [Abstract][Full Text] [Related]
19. Synthetic Neoepitopes of the Transglutaminase-Deamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease. Choung RS; Khaleghi Rostamkolaei S; Ju JM; Marietta EV; Van Dyke CT; Rajasekaran JJ; Jayaraman V; Wang T; Bei K; Rajasekaran KE; Krishna K; Krishnamurthy HK; Murray JA Gastroenterology; 2019 Feb; 156(3):582-591.e1. PubMed ID: 30342033 [TBL] [Abstract][Full Text] [Related]